glp-1 dialysis Target Trial of Glucagon-Like Peptide-1 Agonists versus Dipeptidyl Peptidase-4 Inhibitors and Mortality in Hemodialysis Potential Mechanisms for Pro-Vascular Benefit
Description
Endocrinology Teams Top Recommendation
Take our 60-second quiz to find the best match for your goals, budget, and lifestyle.
Edelman answers a common question about how they can be included in a diabetes management regimen with regard to metformin.
Moringa and Ozempic can potentially be combined, but their shared gastrointestinal effects and limited interaction data require careful provider guidance
